Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1993-12-17
1997-04-15
Chan, Christina Y.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 15, 530326, 530327, A61K 3800, C07K 708
Patent
active
056209550
ABSTRACT:
Bombesin is an amphibian peptide that has a structure closely related to that of several mammalian peptides, including Gastrin Releasing Peptide (GRP) and Neuromedins B and C. Bombesin, GRP and related peptides exert their in vivo effects by binding to specific receptors present on cells of the gastrointestinal tract, the central nervous system, and tumors. The invention relates to novel bombesin derivatives which act as bombesin receptor antagonists by blocking the binding of bombesin, GRP or related peptides to cellular receptors. By blocking the binding of bombesin, GRP and related peptides to cellular receptors on cancer cells, these antagonists inhibit the growth of tumor cells that respond to the growth-promoting action of bombesin. These antagonists are expected to block the binding of bombesin, GRP or related peptides to similar receptors on cells in the gastrointestinal tract or the central nervous system. Thus, these antagonists have therapeutic use in the treatment or prevention of conditions mediated by bombesin, GRP or related peptides, including cancer and gastrointestinal disorders such as peptic ulcer, pancreatitis, and feeding disorders.
REFERENCES:
patent: 4943561 (1990-07-01), Heimbrook et al.
patent: 5019647 (1991-05-01), Riemen et al.
patent: 5169862 (1992-12-01), Burke et al.
patent: 5217955 (1993-06-01), Bogden et al.
patent: 5244883 (1993-09-01), Cai et al.
Halpern, "New Conc. Allergy Clin. Immunol.", Proc. Int. Congr. Allergol., 7th, (1971). Abstract.
Knight et al. "Society for Neuroscience", Abstracts, vol. 19, Part 2. (1993), p. 1270. Ab #525.7.
Bertaccini et al., "Gastrin Release By Bombesin in the Dog", Br. J. Pharmacol. 52:219-225 (1974).
Brambilla et al., "Heterotransplantation of Small Cell Lung Carcinoma into Nude Mice", Cancer 64:1238-1247 (Sep. 15, 1989).
Camble et al., "N-Isobutyryl-His-Trp-Ala-Val-D-Ala-His-Leu-NHMe (ICI 216140) A Potent in vivo antagonist analogue of bombesin/gastrin releasing peptide (Bn/GRP) derived from the C-terminal sequence lacking the final methionine residue", Life Sci. 45:1521-1527 (1989).
Camble et al., "ICI 216140 and other potent in vivo antagonist analogs of bombesin/gastrin-releasing peptide", Peptides: Chemistry, Structure & Biology, Riviers et al., eds., ESCOM, Leiden pp. 174-176 (1990).
deCastiglione et al., "Irreversible ligands for bombesin receptors", Peptides: Chemistry, Structure & Biology, Riviers et al. eds., ESCOM, Leiden pp. 168-170 (1990).
Coy et al., "Progress in the Development of Competitive Bombesin Antagonists", Ann. N.Y. Acad. Sci. 547:150-157 (1988).
Coy et al., "Probing Peptide Backbone Function in Bombesin", J. Biol. Chem. 263:5056-5060 (Apr. 15, 1988).
Coy et al., "Short-Chain Pseudopeptide Bombesin Receptor Antagonists with Enhanced Binding Affinities for Pancreatic Acinar and Swiss 3T3 Cells Display Strong Antimitotic Activity", J. Biol. Chem. 264:14691-14697 (Sep. 5, 1989).
Coy et al., "Short Chain Bombesin Pseudopeptides with Potent Bombesin Receptor Antagonist Activity in Rat and Guinea Pig Pancreatic Acinar Cells", European J. Pharmacol. 190:31-38 (1990).
Crawley, J., "Comparative Distribution of Cholecystokinin and Other Neuropeptides", Ann. N.Y. Acad. Sci. 448:1-8 (Jul. 5, 1985).
Cuttitta et al., "Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer", Nature 316:823-826 (Aug. 29, 1985).
Erspamer et al., "Nomenclature Meeting: Report and Recommendations", Bombesin-Like Peptides in Health and Disease: Annals N.Y. Acad. Sci. 547:1-2 (1988).
Erspamer, V., "Discovery, Isolation, and Characterization of Bombesin-like Peptides", Bombesin-Like Peptides in Health and Disease: Annals N.Y. Acad. Sci. 547:3-9 (1988).
Gibbs et al., "Bombesin suppresses feeding in rats", Nature 282:208-210 (Nov. 8, 1979).
Heimbrook et al., "Carboxyl-terminal Modification of a Gastrin Releasing Peptide Derivatives Generates Potent Antagonists", J. Biol. Chem. 264:11258-11262 (Jul. 5, 1989).
Howard et al., "Bombesin-induced residual stimulation of amylase release from mouse pancreatic acini", Am. J. Physiol. 248:G196-199 (1985).
Kim et al., "C-terminal modified bombesin and litorin analogs with potent in vitro and in vivo antiproliferative activity", Peptides: Chemistry, Structure & Biology, Riviers et al., eds., ESCOM, Leiden, pp. 182-184 (1990).
Knight et al., "Design of a cyclic bombesin analog", Peptides: Chemistry, Structure & Biology, Riviers et al., eds., ESCOM, Leiden, pp. 185-187 (1990).
Knight et al., "Bombesin Antagonists: Synthesis and Inhibitory Action on Small Cell Lung Carcinoma (SCLC) Tumor Growth and Pancreatic Acinar Cell Function", Thirteenth American Peptide Symposium; Peptide Inhibitors:P523 (Jun. 1993).
Knight et al., "Biological Activity of a Potent Bombesin Receptor Antagonist", Soc. Neurosci. Abst. 19(II):525.7 (Nov. 1993).
Leban et al., "Development of potent gastrin-releasin peptide antagonist having a D-Pro-.psi.(CH.sub.2 NH)-Phe-NH.sub.2 C terminus", Proc. Natl. Acad. Sci. USA 90:1922-1926 (Mar. 1993).
Leban et al., "Structure-Activity Relationship Study of Gastrin-Releasing Peptide Antagonists Having a C-Terminal DPRO.psi.(CH.sub.2 NH)PHE-NH.sub.2 ", Thirteenth American Peptide Symposium; Biologically Active Peptides:P344 (Jun. 1993).
Mahmoud et al., "Small Cell Lung Cancer Bombesin Receptors are Antagonized by Reduced Peptide Bond Analogues", Life Sci. 44:367-373 (1989).
Mahmoud et al., "[Psi.sup.13,14 ] Bombesin Analogues Inhibit Growth of Small Cell Lung Cancer in Vitro and in Vivo", Cancer Res. 51:1798-1802 (Apr. 1, 1991).
Marki et al., "Bombesin Analogs: Effects on Thermoregulation and Glucose Metabolism", Peptides 2:169-177 (1981).
McDonald et al., "Characterization of a Gastrin Releasing Peptide from Porcine non-antral Gastric Tissue", Biochem. & Biophys. Res. Comm. 90:227-233 (Sep. 12, 1979).
Minamino et al., "Neuromedin B: A Novel Bombesin-Like Peptide Identified in Porcine Spinal Cord", Biochem. & Biophys. Res. Comm. 114:541-548 (Jul. 29, 1983).
Minamino et al., "Neuromedin C: A Bombesin-Like Peptide Identified in Porcine Spinal Cord", Biochem. & Biophys. Res. Comm. 119:14-20 (Feb. 29, 1984).
Mokotoff et al., "Novel GRP analogs which are potent antagonists of bombesin-like peptides", Peptides: Chemistry, Structure & Biology, Riviers et al., eds., ESCOM, Leiden pp. 63-65 (1990).
Moody et al., "Bombesin: Specific binding to rat brain membranes", Proc. Natl. Acad. Sci. USA 75:5372-5376 (Nov. 1978).
Moody et al., "Bombesin-like Peptides in Rat Brain: Quantitation and Biochemical Characterization", Biochem. & Biophys. Res. Comm. 90:7-14 (Sep. 12, 1979).
Moody et al., "High Affinity Receptors for Bombesin/GRP-Like Peptides on Human Small Cell Lung Cancer", Life Sci. 37:105-113 (1985).
Moody et al., "BW-2258: A New Gastrin Releasing Peptide Receptor Antagonist", Soc. Neurosc. Abst. 19(II):525.10 (Nov. 1993).
Mukai et al., "Antagonism by GRP(18-27) and Substance P Analogues on Insulin Release Stimulated by GRP(18-27)", Peptides 11:173-175 (1990).
Mulshine et al., "Clinical Use of a Monoclonal Antibody to Bombesin-like Peptide in Patients with Lung Cancer", Annal. N.Y. Acad. Sci. 547:360-372 (1988).
Nakajima et al., "Immunohistochemical Study of Small Cell Lung Carcinoma; With Special Reference to the Neuroendocrine Markers Aromatic L-Amino Acid Decarboxylase and Gastrin-Releasing Peptide", Jpn. J. Clin. Oncol. 16:223-233 (Sep. 1986).
Porrecca et al., "Central and Peripheral Visceral Effects of Bombesin", Annal. N.Y, Acad. Sci. 547:194-203 (1988).
Pullan et al., "Ectopic production of methionine enkephalin and beta-endorphin", Br. Med. J. 1:758-759 (Mar. 15, 1980).
Rivier et al., "Bombesin, Bombesin Analogues, and Related Peptides: Effects on Thermoregulation", Biochem. 17:1766-1771 (1978).
Rozengurt, E., "Early Signals in the Mitogenic Response", Science 234:161-166 (Oct. 10, 1986).
Saeed et al., "Effect of Substitutions in Position 12 of Bombesin on Antagonist Activity", Peptides 10:597-603 (1989).
Sigma Catalogue: Peptides and Amino Acids, p. 30, (1993-1994).
Spindel & Krane, "Molecular Biology & Bombesin-Like Peptides", Bombesin-Like
Chandrasekhar Bhaskar
Knight Martha
Takahashi Kazuyuki
Chan Christina Y.
Marshall S. G.
Peptide Technologies Corporation
LandOfFree
Bombesin receptor antagonists and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bombesin receptor antagonists and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bombesin receptor antagonists and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-360747